0 likes | 24 Vues
Want to partner with a Contract Research Organization in Latin America that puts your research first? With bioaccessu00ae help, you've arrived at the right destination! Our expert team delivers top-class results, always meeting or even exceeding your expectations. We'll do the details so you can focus on what matters most! Visit us: https://www.bioaccessla.com/solutions
E N D
CONTRACT RESEARCH CONTRACT RESEARCH ORGANIZATION IN ORGANIZATION IN LATIN AMERICA LATIN AMERICA Accelerating Medtech innovations with expert clinical trials across Latin America for over 20 years.
Introduction to bioaccess® Who We Are Leading CRO in Latin America: bioaccess® is an expert in Medtech clinical research, providing world-class services. Specialized Services: Focused on delivering cost-effective, high-quality clinical trial solutions for Medtech startups. Mission: To help startups accelerate clinical study results, enabling them to advance quickly towards regulatory approvals and commercialization. Offices in Miami and San Francisco Partnerships with U.S. and Colombian organizations
bioaccess® Expertise Expertise in Medtech Clinical Trials Specialized in Early-Feasibility Studies (EFS), First- In-Human (FIH) Studies, Pilot Studies, Pivotal Studies, and Post-Market Clinical Follow-Up (PMCF). 20+ Years of Experience in Medtech clinical trials, ensuring regulatory approval and trial data reliability. Helping Medtech companies achieve their goals: FDA approval, fundraising, and acquisition success.
Why Latin America? Why Conduct Clinical Research in Latin America? Cost-Effective Solutions: Latin America offers affordable clinical trial costs compared to other regions. Speed: Faster regulatory approvals and streamlined processes. Expertise: Access to highly experienced clinical research professionals. Strategic Location: Proximity to the U.S. with access to untapped patient populations. bioaccess® optimizes Contract Research Organization in Latin America to bring certainty in the clinical trial process.
THANK YOU We hope that the presentation we have delivered is useful.